References
Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells.Nature 1988;332:411–415.
Tahara A, Kohno M, Yanagi S, et al. Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal angioplasty.Metabolism 1991;40:1235–1237.
Malatino LS, Grassi R, Stancanelli B, et al. Release of immunoreactive endothelin from the heart during percutaneous transluminal coronary angioplasty.Am Heart J 1993;126:700–702.
Vanhoutte PM. Is endothelin involved in the pathogenesis of hypertension?Hypertension 1993;21:747–751.
Rubanyi GM, Vanhoutte PM. Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium.J Physiol 1985;364:45–56.
Simonson MS, Dunn MJ. The molecular mechanisms of cardiovascular and renal regulation by endothelin peptides.J Lab Clin Med 1992;119:622–639.
Schiffrin EL, Deng LY, Larochelle P. Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertension patients.J Hypertens 1992;10:437–444.
Kyriakides ZS, Kremastinos DT, Muchelakakis NA, Matsakas EP, Demovelis T, Toutouzas PK. Coronary collateral circulation in coronary artery disease and systemic hypertension.Am J Cardiol 1991;67:687–690.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kyriakides, Z.S., Markianos, M., Iliodromitis, E. et al. Peripheral vein plasma endothelin-1 levels during coronary angioplasty increase only in normotensive patients. Cardiovasc Drug Ther 8, 775–777 (1994). https://doi.org/10.1007/BF00877127
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00877127